Microglia and the pathogenesis of spongiform encephalopathies

Brain Research Reviews

Volumn 35, Issue 1, 2001, Pages 55-72

  Rezaie, P ^a   Lantos, P L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CJD; Inflammation; Neuronal degeneration; Spongiform vacuolation

Indexed keywords

CELL PROTEIN; CHEMOKINE; PRION PROTEIN;

ALPHA HELIX; APOPTOSIS; ASTROCYTOSIS; BETA SHEET; BRAIN SPONGIOSIS; CELL ACTIVATION; CONFORMATIONAL TRANSITION; CREUTZFELDT JAKOB DISEASE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; INFLAMMATION; MICROGLIA; MOLECULAR INTERACTION; MONONUCLEAR PHAGOCYTE; NERVE REGENERATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCRAPIE; TRANSGENIC ANIMAL;

ANIMALS; ENCEPHALITIS; HUMANS; MICROGLIA; PRION DISEASES;

EID: 0035098569     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(01)00042-X     Document Type: Review

References (194)

1. Externalisation of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine-displaying apoptotic cells are phagocytosed by microglia
2. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
3. Central neuron-glia and glial-glial interactions following axon injury
4. Glial responses to synaptic damage and plasticity
5. How is Creutzfeldt-Jakob disease acquired?
6. Basic FGF in astroglial, microglial and neuronal cultures: Characterisation of binding sites and modulation of release by lymphokines and trophic factors
7. Prion protein is strongly immunolocalised at the postsynaptic domain of human normal neuromuscular junctions
8. Prion diseases and the immune system
9. Differential macrophage responses in the peripheral and central nervous system during Wallerian degeneration of axons
10. Chemokines and their receptors in neurobiology: Perspectives in physiology and homeostasis
11. Microglial activation varies in different models of Creutzfeldt-Jakob disease
12. Surveillance, intervention and cytotoxicity: Is there a protective role of microglia?
13. Microglia is a component of the prion protein amyloid plaque in Gerstmann-Sträussler-Scheinker syndrome
14. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor
15. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease
16. Vacuolation in murine prion diseases: An informative artifact
17. The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate
18. Evidence for an early inflammatory response in the central nervous system of mice with scrapie
19. Proliferating cell nuclear antigen immunohistochemistry in astrocytes in experimental Creutzfeldt-Jacob disease and in human Kuru, Creutzfeldt-Jacob disease and Gerstmann-Sträussler-Scheinker syndrome
20. Normal development of nerve-muscle synapses in mice lacking the prion protein gene
21. Prion protein peptide neurotoxicity can be mediated by astrocytes
22. Microglial expression of the prion protein
23. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells
24. Microglia and prion disease: A review
25. Prion protein expression in muscle cells and toxicity of a prion protein fragment
26. A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia
27. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture
28. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
29. 'New variant' Creutzfeldt-Jakob disease and bovine spongiform encephalopathy
30. Amyloid plaques in the brains of mice infected with scrapie: Morphological variation and staining properties
31. Scrapie strain variation and its implications
32. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie
33. Mice devoid of PrP are resistant to scrapie
34. Brain macrophages stimulate neurite growth and regeneration by secreting thrombospondin
35. Truncated forms of the human prion protein in normal brain and in prion diseases
36. Synaptic degeneration is the primary neuropathological feature in prion disease: A preliminary study
37. Transmission of fatal familial insomnia to laboratory animals
38. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein
39. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
40. Prion protein is necessary for normal synaptic function
41. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins
42. c glycoform heterogeneity as a function of brain region: Implications for selective targeting of neurons by prion strains
43. Transforming growth factor-beta1 in adult human microglia and its stimulated production by interleukin-1
44. The key must fit: Macrophages transport prion infection to the central nervous system and may determine the sites of infection within it
45. The role of macrophages in wound repair: A review
46. Wound healing: The role of the macrophage and other immune cells
47. Contaminated surgical instruments and variant Creutzfeldt-Jakob disease
48. Early changes in tyrosine hydroxylase and glutamate decarboxylase activity in the golden hamster striatum after intracerebral inoculation of the nigrostriatal system with scrapie agent (strain 263K)
49. Changes in tyrosine hydroxylase, glutamic acid decarboxylase and choline acetyl transferase after local microinoculation of scrapie agent into the nigrostriatal system of the golden hamster
50. Microglial activation in Alzheimer Disease: Association with APOE genotype
51. Microglia and the development of spongiform change in Creutzfeldt-Jacob Disease
52. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function
53. Neurotoxicity of a prion protein fragment
54. A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy
55. Ultrastructural localisation of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus
56. The sequential development of the brain lesions of scrapie in three strains of mice
57. Studies of the lymphoreticular system in the pathogenesis of scrapie: The role of spleen and thymus
58. Predicted alpha-helical regions of the prion protein when synthesised as peptides form amyloid
59. Predicted vCJD mortality in Great Britain
60. Role of microglia in neuronal cell death in prion disease
61. Neuronal death in scrapie-infected mice is due to apoptosis
62. Characterisation of ameboid microglia isolated from developing mammalian brain
63. Interleukin-1 is an astroglial growth factor in the developing brain
64. c) at the neuromuscular junction
65. New variant Creutzfeldt-Jakob disease
66. Synaptic stripping in the human facial nucleus
67. Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease
68. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic cell death: A cautionary note
69. Neuronal apoptosis in Creutzfeldt-Jakob disease
70. Relationship of microglia and scrapie amyloid-immunoreactive plaques in Kuru, Creutzfeldt-Jacob disease and Gerstmann-Sträussler syndrome
71. Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies
72. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease
73. Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases
74. Differences in glial, synaptic and motoneuron responses in the facial nucleus of the rat brainstem following facial nerve resection and nerve suture reanastomosis
75. Abundant defective viral particles budding from microglia in the course of retroviral spongiform encephalopathy
76. Inflammatory signals induce neurotrophin expression in human microglial cells
77. Patch-clamp analysis of synaptic transmission to cerebellar purkinje cells of prion protein knockout mice
78. 2+ in microglia activated by prion protein fragment
79. Chemokines and chemokine receptor expression in the central nervous system
80. Bone marrow-derived elements in the central nervous system: An immunohistochemical and ultrastructural study of rat chimeras
81. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
82. The same prion strain causes vCJD and BSE
83. Spontaneous neurodegeneration in transgenic mice with mutant prion protein
84. β-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity
85. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease
86. Mammalian prion proteins
87. Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry
88. Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice
89. Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro
90. Macrophage cell-conditioned medium promotes cholinergic differentiation of undifferentiated progenitors and synergises with nerve growth factor action in the developing basal forebrain
91. Population control of microglia: Does apoptosis play a role?
92. Regulation of CD44 in the regenerating mouse facial motor nucleus
93. Microglia and Alzheimer's disease
94. Ferritin immunohistochemistry as a marker for microglia
95. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease
96. Autoradiographic studies on histogenesis of brain macrophages in the mouse
97. β-Amyloid protein enhances macrophage production of oxygen free radicals and glutamate
98. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha
99. A crucial role for B cells in neuroinvasive scrapie
100. The macrophages: Effector cell wound repair
101. Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease
102. Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord
103. Cell death in prion disease
104. Bone marrow-derived elements and resident microglia in brain inflammation
105. Contaminated surgical instruments and variant Creutzfeldt-jakob disease
106. Modulation of macrophage and microglial responses to axonal injury in the peripheral and central nervous systems
107. Peripheral nerve-stimulated macrophages stimulate a peripheral nerve-like regenerative response in rat transected optic nerve
108. Transplantation of activated macrophages overcomes central nervous system regrowth failure
109. Microglia and macrophages are major sources of locally produced transforming growth factor-beta 1 after transient middle cerebral artery occlusion in rats
110. Macrophages, wound repair and angiogenesis
111. Sequential expression of surface antigens and transcription factor NfkappaB by hippocampal cells in excitotoxicity and experimental epilepsy
112. Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: Temporally distinct expression of midkine and pleiotrophin
113. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus
114. Beta-amyloid induced IL-1 beta release from an activated human monocyte cell line is calcium and G-protein dependent
115. beta-amyloid induces increased release of interleukin-1 beta from lipopolysaccharide activated human monocytes
116. Detection of apoptosis in murine scrapie
117. T-lymphocyte activation and the cellular form of the prion protein
118. Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro
119. Subacute spongiform encephalopathy (Creutzfeldt-Jakob Disease) - The nature and progression of spongiform change
120. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP-1 monocytes
121. Amyloid fibrils activate tyrosine kinase-dependent signalling and superoxide production in microglia
122. Mechanisms of cell death in Alzheimer's disease - Immunopathology
123. The importance of inflammatory mechanisms in Alzheimer disease
124. Cellular uptake of the prion protein fragment PrP 106-126 in vitro
125. Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning
126. Isolation and characterisation of macrophages from scrapie-infected mouse brain
127. Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration
128. A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation
129. Reactive microglia in Creutzfeldt-Jacob disease
130. Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jacob disease via intra-peritoneal route: A sequential study
131. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jacob disease
132. Microglia-derived plasminogen enhances neurite outgrowth from explant cultures of rat brain
133. Microglia-derived elastase produces low-molecular weight plasminogen that enhances neurite outgrowth in rat neocortical explant cultures
134. Temporary colonisation of the site of lesion by macrophages is a prelude to the arrival of regenerated axons in injured goldfish optic nerve
135. Neurotrophins: Signals between the nervous and immune systems
136. An immunological approach to prion diseases
137. Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells
138. Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob Disease phenotype
139. The blood-brain barrier and the inflammatory response
140. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines
141. Failure to demonstrate a humoral immune response to scrapie infection in mice
142. Expression of basic fibroblast growth factor and its receptors in human fetal microglial cells
143. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord
144. Molecular biology and pathogenesis of prion diseases
145. The prion diseases
146. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrP (Sc) in the same brain
147. Grafting of microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth
148. The plasminogen activator system in neurons and glia during motoneuron regeneration
149. Colonisation of the developing human brain and spinal cord by microglia: A review
150. Inflammation and axonal regeneration
151. Microglia and neurodegeneration
152. Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice
153. Inflammatory response and retinal ganglion cell degeneration following intraocular injection of ME7
154. Chemokines and receptors in HIV encephalitis
155. Immunohistochemical study of microglia in the Creutzfeldt-Jacob diseased brain
156. Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies
157. Cell biology of wound healing
158. Microglial motility in the rat facial nucleus following peripheral axotomy
159. Production of basic fibroblast growth factor in cultured brain microglia
160. Cellular activation in neuroregeneration
161. Scrapie in the central nervous system: Neuroanatomical spread of infection and Sinc control of pathogenesis
162. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice
163. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
164. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein
165. Production of basic fibroblast growth factor in cultured rat brain microglia
166. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
167. Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage-sensitive calcium channels
168. Variant Creutzfeldt-jakob disease: An update
169. Changes in a protein-nucleic acid complex from synaptic plasma membrane of scrapie-infected mouse brain
170. The role of microglia and macrophages in the pathophysiology of the CNS
171. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro
172. Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia
173. Transmission of Creutzfeldt-Jacob disease from humans to transgenic mice expressing chimeric human-mouse prion protein
174. Mechanisms governing neuronal degeneration and axonal regeneration in the mature retinofugal system
175. Brain macrophages: On the role of pericytes and perivascular cells
176. Apoptosis of cultured microglia by the deprivation of macrophage colony-stimulating factor
177. The neurotrophic analogue of ACTH (4-9) reduces the perineuronal microglial reaction after rat facial nerve crush
178. Cyclo-oxygenase 2 is highly expressed in microglia-like cells in a murine model of prion disease
179. The complex of microglial cells and amyloid star in three-dimensional reconstruction
180. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95)
181. Characterisation of the microglial response in murine scrapie
182. PrP deposition, microglial activation and neuronal apoptosis in murine scrapie
183. Monocyte recruitment into the scrapie-affected brain
184. Immunocytochemical appearance of cytokines, prostaglandin E-2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations
185. Ultrastructure of the cells forming amyloid fibrils in Alzheimer's disease and scrapie
186. General principles of wound healing
187. The role of chemokines in the pathogenesis of multiple sclerosis
188. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
189. Transforming growth factor-beta1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression
190. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia
191. Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes
192. Extensive degeneration of catecholaminergic neurons to scrapie agent 87V in the brains of IM mice
193. Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis
194. Neuron-microglia interactions in vitro